Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Weissman

Showing results (231-240 of 293) with videos related to

Pageof 30
Sort By:
Nature Communications|April 21, 2023
Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female miceEakachai Prompetchara, Chutitorn Ketloy, Mohamad-Gabriel Alameh, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 28, 2026
High-Throughput In Vivo Screening Using Barcoded mRNA Identifies Lipid Nanoparticles With Extrahepatic Tropism for In Situ ImmunoengineeringAlex G Hamilton, Ajay S Thatte, Junchao Xu, et al.
Science (New York, N.Y.)|November 24, 2022
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypesClaudia P Arevalo, Marcus J Bolton, Valerie Le Sage, et al.
Cell Stem Cell|November 29, 2023
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosisFatima Rizvi, Yu-Ri Lee, Ricardo Diaz-Aragon, et al.
Science Immunology|June 6, 2025
An <i>Il12</i> mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responsesEmily A Aunins, Anthony T Phan, Mohamad-Gabriel Alameh, et al.
Pathogens & Immunity|January 31, 2022
Is France Once Again Looking for a Scapegoat?Michael M Lederman, Jeffrey S Flier, Peter Hale, et al.
NPJ Vaccines|October 1, 2024
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infectionElena N Atochina-Vasserman, Lisa C Lindesmith, Carmen Mirabelli, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Multi-stage-mixing to control the supramolecular structure of lipid nanoparticles, thereby creating a core-then-shell arrangement that improves performance by orders of magnitudeJia Nong, Xijing Gong, Quang Minh Dang, et al.
Immunity|December 9, 2020
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody GenerationKatlyn Lederer, Diana Castaño, Daniela Gómez Atria, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
In vivo reprogramming of cytotoxic effector CD8 <sup>+</sup> T cells via fractalkine-conjugated mRNA-LNPAngela R Corrigan, Shin Foong Ngiow, Maura Statzu, et al.
Pageof 30

Showing results (231-240 of 293) with videos related to

Sort By:
Pageof 30
Nature Communications|April 21, 2023
Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female miceEakachai Prompetchara, Chutitorn Ketloy, Mohamad-Gabriel Alameh, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 28, 2026
High-Throughput In Vivo Screening Using Barcoded mRNA Identifies Lipid Nanoparticles With Extrahepatic Tropism for In Situ ImmunoengineeringAlex G Hamilton, Ajay S Thatte, Junchao Xu, et al.
Science (New York, N.Y.)|November 24, 2022
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypesClaudia P Arevalo, Marcus J Bolton, Valerie Le Sage, et al.
Cell Stem Cell|November 29, 2023
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosisFatima Rizvi, Yu-Ri Lee, Ricardo Diaz-Aragon, et al.
Science Immunology|June 6, 2025
An <i>Il12</i> mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responsesEmily A Aunins, Anthony T Phan, Mohamad-Gabriel Alameh, et al.
Pathogens & Immunity|January 31, 2022
Is France Once Again Looking for a Scapegoat?Michael M Lederman, Jeffrey S Flier, Peter Hale, et al.
NPJ Vaccines|October 1, 2024
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infectionElena N Atochina-Vasserman, Lisa C Lindesmith, Carmen Mirabelli, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Multi-stage-mixing to control the supramolecular structure of lipid nanoparticles, thereby creating a core-then-shell arrangement that improves performance by orders of magnitudeJia Nong, Xijing Gong, Quang Minh Dang, et al.
Immunity|December 9, 2020
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody GenerationKatlyn Lederer, Diana Castaño, Daniela Gómez Atria, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
In vivo reprogramming of cytotoxic effector CD8 <sup>+</sup> T cells via fractalkine-conjugated mRNA-LNPAngela R Corrigan, Shin Foong Ngiow, Maura Statzu, et al.
Pageof 30